Suppr超能文献

用纳米颗粒调节破骨细胞:骨质疏松症治疗的新途径?

Modulating osteoclasts with nanoparticles: A path for osteoporosis management?

机构信息

School of Pharmacy, University of Nottingham, Nottingham, UK.

Department of Pharmacology, Pharmacy and Pharmaceutical Technology, I+D Farma Group (GI-1645), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

出版信息

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jul-Aug;15(4):e1885. doi: 10.1002/wnan.1885. Epub 2023 Apr 10.

Abstract

Osteoclasts are the cells responsible for the bone resorption process during bone remodeling. In a healthy situation, this process results from an equilibrium between new matrix formation by osteoblast and matrix resorption by osteoclast. Osteoporosis (OP) is a systemic bone disease characterized by a decreased bone mass density and alterations in bone microarchitecture, increasing fracture predisposition. Despite the variety of available therapies for OP management there is a growing gap in its treatment associated to the low patients' adherence owing to concerns related with long-term efficacy or safety. This makes the development of new and safe treatments necessary. Among the newly developed strategies, the use of synthetic and natural nanoparticles to modulate osteoclasts differentiation, activity, apoptosis or crosstalk with osteoblasts have arisen. Synthetic nanoparticles exert their therapeutic effect either by loading antiresorptive drugs or including molecules for osteoclasts gene regulation. Moreover, this control over osteoclasts can be improved by their targeting to bone extracellular matrix or osteoclast membranes. Furthermore, natural nanoparticles, also known as extracellular vesicles, have been identified to play a key role in bone homeostasis. Consequently, these systems have been widely studied to control osteoblasts and osteoclasts under variable environments. Additionally, the ability to bioengineer extracellular vesicles has allowed to obtain biomimetic systems with desirable characteristics as drug carriers for osteoclasts. The analyzed information reveals the possibility of modulating osteoclasts by different mechanisms through nanoparticles decreasing bone resorption. These findings suggest that controlling osteoclast activity using nanoparticles has the potential to improve osteoporosis management. This article is categorized under: Implantable Materials and Surgical Technologies > Nanomaterials and Implants Implantable Materials and Surgical Technologies > Nanotechnology in Tissue Repair and Replacement Nanotechnology Approaches to Biology > Nanoscale Systems in Biology.

摘要

破骨细胞是骨重建过程中负责骨吸收的细胞。在健康的情况下,这个过程是由成骨细胞新基质形成和破骨细胞基质吸收之间的平衡产生的。骨质疏松症(OP)是一种系统性骨病,其特征是骨量密度降低和骨微结构改变,增加骨折易感性。尽管有多种治疗 OP 的方法,但由于对长期疗效或安全性的担忧,患者的依从性较差,导致治疗效果存在差距。这使得有必要开发新的安全治疗方法。在新开发的策略中,使用合成和天然纳米粒子来调节破骨细胞分化、活性、凋亡或与成骨细胞的串扰已经出现。合成纳米粒子通过负载抗吸收药物或包括破骨细胞基因调控的分子来发挥其治疗作用。此外,通过将其靶向到骨细胞外基质或破骨细胞膜,可以改善对破骨细胞的控制。此外,也被称为细胞外囊泡的天然纳米粒子已被确定在骨稳态中发挥关键作用。因此,这些系统已被广泛研究用于在不同环境下控制成骨细胞和破骨细胞。此外,生物工程细胞外囊泡的能力允许获得具有理想特性的仿生系统,作为破骨细胞的药物载体。分析的信息表明,通过纳米粒子可以通过不同的机制来调节破骨细胞,从而减少骨吸收。这些发现表明,使用纳米粒子控制破骨细胞活性有可能改善骨质疏松症的管理。本文归入以下类别:可植入材料和外科技术>纳米材料和植入物可植入材料和外科技术>组织修复和替代中的纳米技术纳米技术生物学方法>生物学中的纳米级系统。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验